ADVERSE EVENTS AFTER INTRAVITREAL INFLIXIMAB (REMICADE)

Authors

Keywords

Journal

Volume 30, Issue 1, Pages 71-80

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2010-01-05

DOI

10.1097/iae.0b013e3181bcef3b

References

View 3 related references

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started